Tuesday, February 04, 2020 9:08:54 AM
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 13, 2019, in a Special Meeting of the Board of Directors of Vivic Corp, ("Company"), the board accepted the resignation of Kun-Teng Liao from the Director position. The resignation of Kun-Teng Liao is due to personal reasons and is not the result of any disagreement or dispute with the Company.
In the same special Board meeting on December 13, 2019, Hwang Liu-Shiang Kung and Huilan Chen became the new Board Directors of the Company.
Hwang Liu-Shiang Kung , 76 years’ old, is a resident of Taiwan (R.O.C). She graduated from Tainan Community University. She is a chairman of Jiexin Investment Co., Ltd from June 2018 till present day. She is a director of Jianyu Material Industry Co., Ltd from September 2017 till present day, a director of Kha Shing Enterprises Co., Ltd. from June 2019 till present day, and a director of Horizon Yacht Co., Ltd. from June 2017 till present day.
Huilan Chen, 51 years’ old, is a US resident. She received her Bachelor’s degree in Business Administration in International Trade from Feng-Chia University, Taichung, Taiwan and her MBA degree from Cleveland State University, Ohio, US. From October 1998 to May 2002, she was the product manager of Tsann Kuen Enterprise Co. Ltd Tainan, Taiwan. From October 2004 to October 2012, she was the Office Manager of Aclor Inc, Georgia, US. From December 2015 to August 2016, she was the Logistic Manager of Uni-All Group Ltd, Georgia, US.
Recent VIVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 06:04:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:33:46 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 02:06:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 05:40:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM